Geriatric emergency departments, designed to shield seniors from the stress and infectious disease risk of the general ED, provide often specialized care with the needs of older patients in mind. There are more than 100 of the units in the US, with more planned, and they may improve care, reduce hospital admissions and facilitate faster discharge of senior patients.
Dog owners can expect loyalty, love and fun from a new pet, but they should also be prepared for the financial responsibility, estimated at $1,314 to $1,843 for the initial year of puppy care and preventive medicine, which can save a lot in the long run. Subsequent years could mean costs of $580 to $875, according to the American Society for the Prevention of Cruelty, with services such as boarding and emergency veterinary medical care pushing costs higher.
University of Wisconsin-Madison researchers reported that women ages 50 to 74 with dense breasts had fewer breast cancer deaths when they were screened yearly rather than every other year, according to a study in Annals of Internal Medicine. Women with lower breast density and average breast cancer risk benefited from mammograms every three years because unnecessary biopsies were prevented, researchers said.
A mutation in the OTULIN gene that results in improper processing of the protein ubiquitin causes a rare inflammatory disease in children called otulipenia that can be treated with anti-tumor necrosis factor inhibitors, NIH researchers reported in Proceedings of the National Academy of Sciences. "This discovery suggests a direction that can be explored for development of new therapies for patients with a wide range of inflammatory diseases," scientist Ivona Aksentijevich said.
A study presented at the American Diabetes Association Scientific Sessions showed that diabetes patients who received insulin glargine or insulin detemir had no significant differences in daily blood glucose levels and episodes of hypoglycemic and severe hypoglycemic events. Researchers evaluated 8,100 diabetes patients and also found no significant differences in mean hospital stay or composite complications such as acute kidney injury, major cardiovascular events, pneumonia and 30-day mortality between the two groups, but those on insulin detemir had higher fasting hypoglycemia than patients on insulin glargine.
Researchers found that type 2 diabetes patients with a genetic risk score of 0, as defined by the genetic variants 10q26 and 5q13, had a reduced cardiovascular mortality in response to intensive glycemic treatment, while no difference was found among those with a GRS of 1 and those with a GRS of 2 or greater had an increased CV mortality. The findings in Diabetes Care were based on an analysis of 6.8 million common variants for genome-wide association with CV mortality among 2,667 white subjects from the Action to Control Cardiovascular Risk in Diabetes intensive treatment arm.
Obesity, especially severe obesity, has a strong link to heart failure that is unexplained by traditional risk factors, researchers reported in the Journal of the American Heart Association. The study found obesity was a bigger factor for heart failure than for other cardiovascular diseases, and researchers said weight loss is critical for heart failure prevention.
Twenty-nine out of 38 countries, including the US, have a more than 75% level of EHR adoption, and most countries reached at least 50%, according to a study in the Journal of the American Informatics Association. Researchers also found that only 12 of 36 countries participating in health information exchange had over 50% HIE, with the US reporting HIE between 50% and 74%.
Philadelphia Mayor Jim Kenney signed into law a bill that will require city playgrounds, parks and recreation centers to be more accessible and to provide fitness equipment for adults of all ages and for children with disabilities or developmental delays. Kenney said the changes will lead to a healthier Philadelphia, and the upgrades will be paid for by revenues from the city's new tax on sweetened beverages.
The three drugmakers that manufacture insulin have raised prices so high that some people with diabetes face monthly costs of as much as $500 and cannot afford the treatment. Prices are significantly higher in the US than in other countries, according to advocacy group T1 International.
- Page 1